On average, fewer than 5% of participants in phase I trials respond successfully to the treatment.
平均来说,在第一期试验中只有不到5%的参与者对于治疗反应良好。
The real state of the world is that five anti-TB molecules are in phase I trials and two are in phase II.
事实情况是,有五种抗肺结核分子正处于试验阶段I,有两种处于试验阶段II。
The same is true of medical researchers recruiting volunteers for clinical trials, especially those known as phase I trials, in which a new drug is tested on people for the first time.
对于医学研究人员也是同样情形。他们招募志愿者参加临床试验,主要是将新药物首次使用于人体的第一阶段试验。
Phase I trials: These first studies in people evaluate how a new drug should be given (by mouth, injected into the blood, or injected into the muscle), how often, and what dose is safe.
一期试验:这些首次在人体上进行的试验评估一个新药应该如何给药(口服,注射入血还是肌肉注射),给药间隔和给药的安全剂量。
Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities?
分子靶向药物I期临床试验:我们更应多注重晚期毒性?
Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities?
分子靶向药物I期临床试验:我们更应多注重晚期毒性?
应用推荐